CL2015000886A1 - Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer. - Google Patents
Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer.Info
- Publication number
- CL2015000886A1 CL2015000886A1 CL2015000886A CL2015000886A CL2015000886A1 CL 2015000886 A1 CL2015000886 A1 CL 2015000886A1 CL 2015000886 A CL2015000886 A CL 2015000886A CL 2015000886 A CL2015000886 A CL 2015000886A CL 2015000886 A1 CL2015000886 A1 CL 2015000886A1
- Authority
- CL
- Chile
- Prior art keywords
- iap
- inhibitors
- cancer
- protein binding
- azaindolins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261712305P | 2012-10-11 | 2012-10-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015000886A1 true CL2015000886A1 (es) | 2015-07-17 |
Family
ID=49304982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015000886A CL2015000886A1 (es) | 2012-10-11 | 2015-04-08 | Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer. |
Country Status (19)
Country | Link |
---|---|
US (1) | US9309248B2 (es) |
EP (1) | EP2906559B1 (es) |
JP (1) | JP6333826B2 (es) |
KR (1) | KR20150067182A (es) |
CN (1) | CN104540825B (es) |
AU (1) | AU2013328870A1 (es) |
CA (1) | CA2880324A1 (es) |
CL (1) | CL2015000886A1 (es) |
CR (1) | CR20150148A (es) |
EA (1) | EA201590656A1 (es) |
ES (1) | ES2623304T3 (es) |
HK (1) | HK1206738A1 (es) |
IL (1) | IL237115A (es) |
MA (1) | MA38009B1 (es) |
MX (1) | MX2015004525A (es) |
PE (1) | PE20150965A1 (es) |
PH (1) | PH12015500399A1 (es) |
SG (1) | SG11201501314TA (es) |
WO (1) | WO2014056871A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016079527A1 (en) | 2014-11-19 | 2016-05-26 | Tetralogic Birinapant Uk Ltd | Combination therapy |
WO2016097773A1 (en) | 2014-12-19 | 2016-06-23 | Children's Cancer Institute | Therapeutic iap antagonists for treating proliferative disorders |
JP2019522633A (ja) | 2016-05-20 | 2019-08-15 | ジェネンテック, インコーポレイテッド | Protac抗体コンジュゲート及び使用方法 |
BR112020000010A2 (pt) * | 2017-07-06 | 2020-07-21 | Janssen Pharmaceutica Nv | derivados substituídos de azaindolina como inibidores de nik |
WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2118985A1 (en) * | 1993-04-02 | 1994-10-03 | Dinesh V. Patel | Heterocyclic inhibitors of farnesyl protein transferase |
CA2447999C (en) * | 2001-05-23 | 2011-04-26 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
WO2006017295A2 (en) * | 2004-07-12 | 2006-02-16 | Idun Pharmaceuticals, Inc. | Tetrapeptide analogs |
EP1907388A1 (en) | 2005-07-15 | 2008-04-09 | F. Hoffmann-Roche AG | Novel heteroaryl fused cyclic amines |
WO2009136290A1 (en) | 2008-05-05 | 2009-11-12 | Aegera Therapeutics, Inc. | Functionalized pyrrolidines and use thereof as iap inhibitors |
US8835393B2 (en) * | 2008-08-02 | 2014-09-16 | Genentech, Inc. | Inhibitors of IAP |
US8232273B2 (en) * | 2008-12-19 | 2012-07-31 | Genentech, Inc. | Heterocyclic compounds and methods of use |
JP5529282B2 (ja) * | 2009-10-28 | 2014-06-25 | ジョイアント ファーマスーティカルズ、インク. | 二量体Smac模倣薬 |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
CA2879870A1 (en) * | 2012-10-11 | 2014-04-17 | F. Hoffmann-La Roche Ag | Azaindolines |
-
2013
- 2013-10-08 ES ES13773766.4T patent/ES2623304T3/es active Active
- 2013-10-08 EA EA201590656A patent/EA201590656A1/ru unknown
- 2013-10-08 US US14/433,216 patent/US9309248B2/en not_active Expired - Fee Related
- 2013-10-08 KR KR1020157008986A patent/KR20150067182A/ko not_active Application Discontinuation
- 2013-10-08 WO PCT/EP2013/070881 patent/WO2014056871A1/en active Application Filing
- 2013-10-08 AU AU2013328870A patent/AU2013328870A1/en not_active Abandoned
- 2013-10-08 MX MX2015004525A patent/MX2015004525A/es unknown
- 2013-10-08 CA CA2880324A patent/CA2880324A1/en not_active Abandoned
- 2013-10-08 EP EP13773766.4A patent/EP2906559B1/en active Active
- 2013-10-08 PE PE2015000475A patent/PE20150965A1/es not_active Application Discontinuation
- 2013-10-08 JP JP2015536090A patent/JP6333826B2/ja not_active Expired - Fee Related
- 2013-10-08 MA MA38009A patent/MA38009B1/fr unknown
- 2013-10-08 CN CN201380042809.4A patent/CN104540825B/zh not_active Expired - Fee Related
- 2013-10-08 SG SG11201501314TA patent/SG11201501314TA/en unknown
-
2015
- 2015-02-05 IL IL237115A patent/IL237115A/en not_active IP Right Cessation
- 2015-02-24 PH PH12015500399A patent/PH12015500399A1/en unknown
- 2015-03-19 CR CR20150148A patent/CR20150148A/es unknown
- 2015-04-08 CL CL2015000886A patent/CL2015000886A1/es unknown
- 2015-07-31 HK HK15107344.1A patent/HK1206738A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US9309248B2 (en) | 2016-04-12 |
KR20150067182A (ko) | 2015-06-17 |
CA2880324A1 (en) | 2014-04-17 |
PH12015500399A1 (en) | 2015-04-27 |
JP6333826B2 (ja) | 2018-05-30 |
CN104540825A (zh) | 2015-04-22 |
JP2015534570A (ja) | 2015-12-03 |
MA38009B1 (fr) | 2018-09-28 |
IL237115A (en) | 2016-12-29 |
US20150266879A1 (en) | 2015-09-24 |
HK1206738A1 (en) | 2016-01-15 |
PE20150965A1 (es) | 2015-06-20 |
EP2906559B1 (en) | 2017-02-08 |
MX2015004525A (es) | 2015-07-06 |
SG11201501314TA (en) | 2015-03-30 |
ES2623304T3 (es) | 2017-07-10 |
EA201590656A1 (ru) | 2015-07-30 |
EP2906559A1 (en) | 2015-08-19 |
MA38009A1 (fr) | 2018-02-28 |
CN104540825B (zh) | 2017-10-24 |
CR20150148A (es) | 2015-04-30 |
AU2013328870A1 (en) | 2015-02-26 |
WO2014056871A1 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2014001547A1 (es) | Compuestos derivados de benzotienilo-pirrolotriazina, como inhibidores de la proteina tirosina quinasa; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento y/o la prevencion de cancer y enfermedades tumorales. | |
CL2014002873A1 (es) | Compuestos derivados de pirimidin-amina o triazin-amina, inhibidores de adn-pk; composicion farmaceutica; y su uso para el tratamiento del cancer. | |
DK3616720T3 (da) | Farmaceutisk sammensætning til cancerbehandling | |
BR112016018555A8 (pt) | Ciclopropilaminas como inibidores de lsd1, seu uso, composição farmacêutica que os compreende e método de inibição de lsd1 | |
NZ719905A (en) | Bicyclic heterocycle compounds and their uses in therapy | |
CL2016002027A1 (es) | Ciclopropilamina como inhibidor de la lsd1 | |
CL2012003415A1 (es) | Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer . | |
CL2016001889A1 (es) | (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1. | |
CL2014000543A1 (es) | Compuestos derivados de imidazopiridazinas sustituidas con amino, inhibidores de la quinasa ,mknk2; metodo de preparacion; compuestos intermediarios y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento del cancer. | |
CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
EA201591509A1 (ru) | Ингибиторы cdc7 | |
CL2015000094A1 (es) | Compuestos derivados de imidazotriazincarbonitrilos, inhibidores de la proteina cinasa; composicion farmaceutica que los comprende; y su uso para tratar el cancer, psoriasis y artritis reumatoide. | |
CL2015003314A1 (es) | Inhibidores de acc y usos de los mismos | |
CL2014001065A1 (es) | Compuestos derivados de piridopirazinas; composicion farmaceutica que los comprende; y su uso para la prevencion o el tratamiento de un estado patologico o afeccion mediada por una fgfr cinasa tal como cancer. | |
CL2015000295A1 (es) | Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades. | |
EA201591591A1 (ru) | Соединения карбазола, применяемые в качестве ингибиторов бромодомена | |
CL2012002189A1 (es) | Compuestos derivados de pirrolidina-2-carboxamidas sustituidas; inhibidores de la interaccion mdm2-p53; composicion farmaceutica; y su uso para el tratamiento del cancer, en particular de tumores solidos. | |
CL2014002257A1 (es) | Compuestos derivados de 6-alquinilo piridinas, como mimeticos smac; composicion farmaceutica que los comprende; y su uso para el tratamiento y/o prevencion del cancer. | |
CL2013001093A1 (es) | Compuestos triciclicos inhibidores de la quinasa pi3 (pi3k); composicion farmaceutica que los comprende; metodo para tratar el cancer; y su uso para el tratamiento del cancer . | |
EA201600204A1 (ru) | Производные хиназолина, фармацевтическая композиция на их основе и их применение для профилактики или лечения опухоли | |
CR20120202A (es) | Métodos y composiciones para tratar cáncer | |
CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
ECSP16008797A (es) | Derivados de heterobicicloaril como inhibidores rorc2 y métodos de uso de los mismos | |
CL2016003074A1 (es) | Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer. | |
CL2015000886A1 (es) | Compuestos derivados de azaindolinas sustituidas, inhibidores de la union de proteinas smac al inhibidor de proteinas de apoptosis (iap) y/o inhibidores de la union de proteina caspasa activada a los iap; composicion farmaceutica que los comprende; metodo para tratar o mejorar un cancer; y su uso para el tratamiento terapeutico y/o profilactico del cancer. |